182 related articles for article (PubMed ID: 32800275)
21. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
22. PRPF4 is a novel therapeutic target for the treatment of breast cancer by influencing growth, migration, invasion, and apoptosis of breast cancer cells via p38 MAPK signaling pathway.
Park S; Han SH; Kim HG; Jeong J; Choi M; Kim HY; Kim MG; Park JK; Han JE; Cho GJ; Kim MO; Ryoo ZY; Choi SK
Mol Cell Probes; 2019 Oct; 47():101440. PubMed ID: 31445970
[TBL] [Abstract][Full Text] [Related]
23. Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis.
Wang XF; Zhou QM; Lu YY; Zhang H; Huang S; Su SB
Expert Opin Ther Targets; 2015 May; 19(5):577-87. PubMed ID: 25828376
[TBL] [Abstract][Full Text] [Related]
24. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
25. Suppression of cathepsin a inhibits growth, migration, and invasion by inhibiting the p38 MAPK signaling pathway in prostate cancer.
Park S; Kwon W; Park JK; Baek SM; Lee SW; Cho GJ; Ha YS; Lee JN; Kwon TG; Kim MO; Ryoo ZY; Han SH; Han JE; Choi SK
Arch Biochem Biophys; 2020 Jul; 688():108407. PubMed ID: 32407712
[TBL] [Abstract][Full Text] [Related]
26. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
[TBL] [Abstract][Full Text] [Related]
27. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
28. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
[TBL] [Abstract][Full Text] [Related]
29. Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling.
Khan S; Shukla S; Sinha S; Lakra AD; Bora HK; Meeran SM
Int J Biochem Cell Biol; 2015 Jan; 58():1-16. PubMed ID: 25448414
[TBL] [Abstract][Full Text] [Related]
30. Glypican-3 expression is silenced in human breast cancer.
Xiang YY; Ladeda V; Filmus J
Oncogene; 2001 Nov; 20(50):7408-12. PubMed ID: 11704870
[TBL] [Abstract][Full Text] [Related]
31. Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells.
Yao G; Yin J; Wang Q; Dong R; Lu J
Biomed Res Int; 2019; 2019():2560650. PubMed ID: 31781603
[TBL] [Abstract][Full Text] [Related]
32. p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.
Hong B; Li H; Zhang M; Xu J; Lu Y; Zheng Y; Qian J; Chang JT; Yang J; Yi Q
Int J Cancer; 2015 Jan; 136(1):34-43. PubMed ID: 24806617
[TBL] [Abstract][Full Text] [Related]
33. Evaluating antitumor activity of antiglypican-3 therapy in experimentally induced skin cancer in mice.
Alyoussef A
Arch Dermatol Res; 2021 May; 313(4):263-273. PubMed ID: 32638071
[TBL] [Abstract][Full Text] [Related]
34. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
35. TrkA overexpression enhances growth and metastasis of breast cancer cells.
Lagadec C; Meignan S; Adriaenssens E; Foveau B; Vanhecke E; Romon R; Toillon RA; Oxombre B; Hondermarck H; Le Bourhis X
Oncogene; 2009 May; 28(18):1960-70. PubMed ID: 19330021
[TBL] [Abstract][Full Text] [Related]
36. ELK1-activated GPC3-AS1/GPC3 axis promotes the proliferation and migration of cervical cancer cells.
Hu R; Zhu Z
J Gene Med; 2019 Aug; 21(8):e3099. PubMed ID: 31168873
[TBL] [Abstract][Full Text] [Related]
37. Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression.
Mao L; Summers W; Xiang S; Yuan L; Dauchy RT; Reynolds A; Wren-Dail MA; Pointer D; Frasch T; Blask DE; Hill SM
Mol Cancer Res; 2016 Nov; 14(11):1159-1169. PubMed ID: 27535706
[TBL] [Abstract][Full Text] [Related]
38. Flavopiridol blocks integrin-mediated survival in dormant breast cancer cells.
Najmi S; Korah R; Chandra R; Abdellatif M; Wieder R
Clin Cancer Res; 2005 Mar; 11(5):2038-46. PubMed ID: 15756030
[TBL] [Abstract][Full Text] [Related]
39. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
40. Galectin-1 induces metastasis and epithelial-mesenchymal transition (EMT) in human ovarian cancer cells via activation of the MAPK JNK/p38 signalling pathway.
Zhu J; Zheng Y; Zhang H; Liu Y; Sun H; Zhang P
Am J Transl Res; 2019; 11(6):3862-3878. PubMed ID: 31312395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
